Cancer Control Program

Cancer Control is focused on improving the current knowledge base for promoting overall reductions in cancer incidence, mortality and morbidity as outlined in Healthy People 2020. Studies include: 1) promoting the decline in tobacco consumption in the United States; 2) improving lifestyle patterns (such as physical activity and nutrition) observed to be protective against cancer; 3) studying the efficacy of cancer prevention efforts; and 4) improving measures of environmental exposure used in cancer prevention and control studies.

The goal of the Cancer Control program (CCP) is to understand and reduce the risk of cancer, cancer recurrence, and cancer mortality; with cross cutting themes of disparities and technology. The aims of the program reflect the expertise of its members across the continuum of cancer control from prevention behaviors and policies, promoting screening uptake, connected care, and survivorship. CCP addresses catchment area issues via its emphasis on research in Hispanics and low-income populations. Researchers use community-based participatory research approaches to address catchment area disparities in health behaviors, including obesity and diabetes.

The Specific Aims of CCP are:
  • To prevent tobacco-related cancers by reducing the prevalence of tobacco product use

  • To prevent obesity-related cancers through lifestyle and community intervention

  • To interrupt the development of cancer through screening, early detection, and testing interventions in premalignant neoplasia

  • To enhance the quality and length of survival of persons diagnosed with cancer through treatment and intervention 


Programmatic aims are unified and integrated by two cross-cutting themes: 
    1. Cancer disparities - Program members seek to understand and reduce factors that contribute to disparities in cancer incidence and mortality, particularly within the catchment area, including underserved groups such as Hispanics.
    2. Technology - Program members use innovative technology, such as mobile devices and online platforms, to improve objective assessment of cancer risk factors, and implement lifestyle interventions.

    Cancer Cell

    Samir Gupta, MD


    Associate Professor of Medicine
    858-822-4499

    John P. Elder, PhD, MPH












    Adjunct Professor of Family Medicine and Public Health
    Distinguished Professor of Public Health, San Diego State University
    619-594-2997